Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd

Freenome Adds University Of Chicago As A Partner For Its Vallania Study

Freenome Adds Renown Health As Partner For The Sanderson Study

Freenome Presents A Subject Population Analysis Of A Clinical Study Using A Multiomics Blood Test For The Early Detection Of Colorectal Cancer

Freenome Partners with Geisinger for the Sanderson Study

Freenome Presents Research Highlighting The Promise of Identifying Drug-Response Biomarker for DLBCL Patients

Freenome Adds Several Community Partners to Clinical Study for the Early Detection of Cancer

Freenome Launches Study of Multiple Cancers Pairing Multiomics with Real-World Data

Freenome Continues Growth, Adds Three New Leaders

Freenome Research Underscores Clinical Utility of Screening Tests That Detect Adenomas

Freenome and Morehouse Present Research on Study Participation Among Black Patients

Largest Clinical Study Validating a Blood-based Colorectal Screening Test Completes Enrollment

Freenome and Merck KGaA, Darmstadt, Germany to Present Data on Combination of Multiomics Profiling and Computational Modeling at AACR Meeting

Freenome Presents Research That Highlights the Significance of Detecting Adenomas in Any Test That Screens for Colorectal Cancer

Lance Baldo Joins Freenome as Chief Medical Officer

Research Highlights Changing Factors that Influence Colorectal Cancer Screening Adherence

Freenome Launches the Vallania Study for the Early Detection of Multiple Cancers

Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRC

Significant Investment Accelerates Freenome’s Multiomics Platform for the Early Detection of Cancer

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

Freenome Partners with Siemens Healthineers for Breast Cancer Research

Morehouse School of Medicine and Freenome Present Research Demonstrating High Enrollment Rates for African Americans in Clinical Trial

Freenome Shows Continued Leadership in Colorectal Cancer Research

Research Shows the Clinical Benefits of Detecting Adenomas

Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers